1.
Product Overview
2.
Research Methodology
3.
Executive Summary
4.
Impact of COVID-19 on Global Genome Sequencing Market
5.
Voice of Customer
5.1.
Factors Contributing to Demand for Genome Sequencing
5.2.
Source of Information
5.3.
Commonly Sequenced Nucleotides
5.4.
Preference, By Technique
5.5.
Demand, By Application
5.6.
Brand Awareness
6. Global Genome
Sequencing Market Outlook
6.1.
Market Size & Forecast
6.1.1.
By Value
6.2.
Market Share & Forecast
6.2.1.
By Nucleotide Sequenced (DNA v/s RNA)
6.2.2.
By Technique (Next Generation Sequencing, PCR, Microarray
Technology, Others)
6.2.3.
By Application (Diagnostics, Drug Discovery &
Development, Precision Medicine, Others)
6.2.4.
By End User (Academic & Research Institutions,
Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, Others)
6.2.5.
By Company (2021)
6.2.6. By
Region
6.3.
Product Market Map
7. North America Genome
Sequencing Market Outlook
7.1.
Market Size & Forecast
7.1.1.
By Value
7.2.
Market Share & Forecast
7.2.1.
By Nucleotide Sequenced
7.2.2.
By Technique
7.2.3.
By Application
7.2.4.
By End User
7.2.5.
By Country
7.3.
North America: Country Analysis
7.3.1.
United States Genome Sequencing Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Nucleotide Sequenced
7.3.1.2.2.
By Technique
7.3.1.2.3.
By Application
7.3.1.2.4.
By End User
7.3.2.
Mexico Genome Sequencing Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Nucleotide Sequenced
7.3.2.2.2.
By Technique
7.3.2.2.3.
By Application
7.3.2.2.4.
By End User
7.3.3.
Canada Genome Sequencing Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Nucleotide Sequenced
7.3.3.2.2.
By Technique
7.3.3.2.3.
By Application
7.3.3.2.4.
By End User
8. Europe Genome
Sequencing Market Outlook
8.1.
Market Size & Forecast
8.1.1.
By Value
8.2.
Market Share & Forecast
8.2.1.
By Nucleotide Sequenced
8.2.2.
By Technique
8.2.3.
By Application
8.2.4.
By End User
8.2.5.
By Country
8.3.
Europe: Country Analysis
8.3.1.
France Genome Sequencing Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Nucleotide Sequenced
8.3.1.2.2.
By Technique
8.3.1.2.3.
By Application
8.3.1.2.4.
By End User
8.3.2.
Germany Genome Sequencing Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Nucleotide Sequenced
8.3.2.2.2.
By Technique
8.3.2.2.3.
By Application
8.3.2.2.4.
By End User
8.3.3.
United Kingdom Genome Sequencing Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Nucleotide Sequenced
8.3.3.2.2.
By Technique
8.3.3.2.3.
By Application
8.3.3.2.4.
By End User
8.3.4.
Italy Genome Sequencing Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Nucleotide Sequenced
8.3.4.2.2.
By Technique
8.3.4.2.3.
By Application
8.3.4.2.4.
By End User
8.3.5.
Spain Genome Sequencing Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Nucleotide Sequenced
8.3.5.2.2.
By Technique
8.3.5.2.3.
By Application
8.3.5.2.4.
By End User
9. Asia-Pacific Genome
Sequencing Market Outlook
9.1.
Market Size & Forecast
9.1.1.
By Value
9.2.
Market Share & Forecast
9.2.1.
By Nucleotide Sequenced
9.2.2.
By Technique
9.2.3.
By Application
9.2.4.
By End User
9.2.5.
By Country
9.3.
Asia-Pacific: Country Analysis
9.3.1.
China Genome Sequencing Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Nucleotide Sequenced
9.3.1.2.2.
By Technique
9.3.1.2.3.
By Application
9.3.1.2.4.
By End User
9.3.2.
India Genome Sequencing Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Nucleotide Sequenced
9.3.2.2.2.
By Technique
9.3.2.2.3.
By Application
9.3.2.2.4.
By End User
9.3.3.
South Korea Genome Sequencing Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Nucleotide Sequenced
9.3.3.2.2.
By Technique
9.3.3.2.3.
By Application
9.3.3.2.4.
By End User
9.3.4.
Japan Genome Sequencing Market Outlook
9.3.4.1.
Market Size & Forecast
9.3.4.1.1.
By Value
9.3.4.2.
Market Share & Forecast
9.3.4.2.1.
By Nucleotide Sequenced
9.3.4.2.2.
By Technique
9.3.4.2.3.
By Application
9.3.4.2.4.
By End User
9.3.5.
Australia Genome Sequencing Market Outlook
9.3.5.1.
Market Size & Forecast
9.3.5.1.1.
By Value
9.3.5.2.
Market Share & Forecast
9.3.5.2.1.
By Nucleotide Sequenced
9.3.5.2.2.
By Technique
9.3.5.2.3.
By Application
9.3.5.2.4.
By End User
10. South America Genome
Sequencing Market Outlook
10.1.
Market Size & Forecast
10.1.1.
By Value
10.2.
Market Share & Forecast
10.2.1.
By Nucleotide Sequenced
10.2.2.
By Technique
10.2.3.
By Application
10.2.4.
By End User
10.2.5.
By Country
10.3.
South America: Country Analysis
10.3.1.
Brazil Genome Sequencing Market Outlook
10.3.1.1.
Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2.
Market Share & Forecast
10.3.1.2.1.
By Nucleotide Sequenced
10.3.1.2.2.
By Technique
10.3.1.2.3.
By Application
10.3.1.2.4.
By End User
10.3.2.
Argentina Genome Sequencing Market Outlook
10.3.2.1.
Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2.
Market Share & Forecast
10.3.2.2.1.
By Nucleotide Sequenced
10.3.2.2.2.
By Technique
10.3.2.2.3.
By Application
10.3.2.2.4.
By End User
10.3.3.
Colombia Genome Sequencing Market Outlook
10.3.3.1.
Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2.
Market Share & Forecast
10.3.3.2.1.
By Nucleotide Sequenced
10.3.3.2.2.
By Technique
10.3.3.2.3.
By Application
10.3.3.2.4.
By End User
11. Middle East and
Africa Genome Sequencing Market Outlook
11.1.
Market Size & Forecast
11.1.1.
By Value
11.2.
Market Share & Forecast
11.2.1.
By Nucleotide Sequenced
11.2.2.
By Technique
11.2.3.
By Application
11.2.4.
By End User
11.2.5.
By Country
11.3.
MEA: Country Analysis
11.3.1.
South Africa Genome Sequencing Market Outlook
11.3.1.1.
Market Size & Forecast
11.3.1.1.1.
By Value
11.3.1.2.
Market Share & Forecast
11.3.1.2.1.
By Nucleotide Sequenced
11.3.1.2.2.
By Technique
11.3.1.2.3.
By Application
11.3.1.2.4.
By End User
11.3.2.
Saudi Arabia Genome Sequencing Market Outlook
11.3.2.1.
Market Size & Forecast
11.3.2.1.1.
By Value
11.3.2.2.
Market Share & Forecast
11.3.2.2.1.
By Nucleotide Sequenced
11.3.2.2.2.
By Technique
11.3.2.2.3.
By Application
11.3.2.2.4.
By End User
11.3.3.
UAE Genome Sequencing Market Outlook
11.3.3.1.
Market Size & Forecast
11.3.3.1.1.
By Value
11.3.3.2.
Market Share & Forecast
11.3.3.2.1.
By Nucleotide Sequenced
11.3.3.2.2.
By Technique
11.3.3.2.3.
By Application
11.3.3.2.4.
By End User
12.
Market Dynamics
12.1.
Drivers
12.2.
Challenges
13.
Market Trends & Developments
14.
Competitive Landscape
14.1.
Company Profiles
14.1.1. Company Details
14.1.2. Financials (As
reported)
14.1.3. Key Market Focus and
Geographical Presence
14.1.4. Pricing of Target
Products
14.1.5. Market positioning
14.2.
Thermo Fisher
Scientific, Inc.
14.3.
Ilumina, Inc.
14.4.
QIAGEN N.V.
14.5.
Eurofins Scientific
SE
14.6.
Agilent
Technologies, Inc.
14.7.
Oxford Nanopore Technologies
Limited
14.8.
F. Hoffmann-La Roche
AG
14.9.
Bio-Rad
Laboratories, Inc.
14.10.
Abbott Laboratories,
Inc.
14.11.
Danaher Corporation
15. Strategic
Recommendations